Mirabegron

Home > API & Intermediate > Inhibitors > Mirabegron Manufacturers > Mirabegron

Mirabegron

CAS NO.： 223673-61-8

FOB Price： NEGOTIABLE Get Latest Price

Specification：＞99%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 25KG/Fibre Drum

Product Detail

Properties

Mirabegron

CAS：223673-61-8

Molecular formula: C21H24N4O2S

Molecular weight: 396.50

Appearance: white to off white powder

Content: more than 99%

Application: for the treatment of adult overactive bladder

Properties

Mirabelon tablets, developed by Estelle pharmaceutical company of Japan, were listed in Japan on September 16, 2011 and approved by the US Food and Drug Administration (FDA) on June 28, 2012 for the treatment of adult overactive bladder (OAB). Mirabelon was the first to be used to treat overactive bladder β 3. Adrenoceptor agonists, whose successful marketing fills the gap β There is a blank of adrenoceptor agonists in the treatment of overactive bladder.

CAS No.

223673-61-8

Formula

C21H24N4O2S

Molecular Mass

396.50600

Exact Mass

396.16200

PSA

128.51000

Logp

3.81730

IUPAC

2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide

Matter Classification

organic

Category

Melting Point

138-140°C

Density

1.313

Boiling Point

690.0±55.0 °C

Appearance

Pale yellow or yellow solid

Acidity and Basicity

alkalinity, reducibility

HS Code

29341090

Send your message to this supplier

To：

Anhui Dexinjia Biopharm Co.,Ltd.

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

b

Send Email

Mirabegron